This report investigates the response of CD8+ T cells to antigens presented by B cells. When C57BL/6 mice were injected with syngeneic B cells coated with the Kb-restricted ovalbumin (OVA) determinant OVA257–264, OVA-specific cytotoxic T lymphocyte (CTL) tolerance was observed. To investigate the mechanism of tolerance induction, in vitro–activated CD8+ T cells from the Kb-restricted, OVA-specific T cell receptor transgenic line OT-I (OT-I cells) were cultured for 15 h with antigen-bearing B cells, and their survival was determined. Antigen recognition led to the killing of the B cells and, surprisingly, to the death of a large proportion of the OT-I CTLs. T cell death involved Fas (CD95), since OT-I cells deficient in CD95 molecules showed preferential survival after recognition of antigen on B cells. To investigate the tolerance mechanism in vivo, naive OT-I T cells were adoptively transferred into normal mice, and these mice were coinjected with antigen-bearing B cells. In this case, OT-I cells proliferated transiently and were then lost from the secondary lymphoid compartment. These data provide the first demonstration that B cells can directly tolerize CD8+ T cells, and suggest that this occurs via CD95-mediated, activation-induced deletion.
Skip Nav Destination
Article navigation
7 December 1998
Article|
December 07 1998
B Cells Directly Tolerize CD8+ T Cells
Sally R.M. Bennett,
Sally R.M. Bennett
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Francis R. Carbone,
Francis R. Carbone
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Tracey Toy,
Tracey Toy
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Jacques F.A.P. Miller,
Jacques F.A.P. Miller
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Search for other works by this author on:
William R. Heath
William R. Heath
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Search for other works by this author on:
Sally R.M. Bennett
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Francis R. Carbone
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Tracey Toy
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Jacques F.A.P. Miller
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
William R. Heath
From the *Immunology Division, The Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia; ‡The Cooperative Research Centre for Vaccine Technology at the Queensland Institute of Medical Research, The Royal Brisbane Hospital, Herston, Queensland 4029, Australia; and the §Department of Pathology and Immunology, Monash Medical School, Prahran, Victoria 3181, Australia
Address correspondence to William R. Heath, Immunology Division, The Walter and Eliza Hall Institute, Post Office The Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia. Phone: 61-3-9345-2482; Fax: 61-3-9347-0852; E-mail: [email protected]
Received:
December 26 1997
Revision Received:
September 15 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (11): 1977–1983.
Article history
Received:
December 26 1997
Revision Received:
September 15 1998
Citation
Sally R.M. Bennett, Francis R. Carbone, Tracey Toy, Jacques F.A.P. Miller, William R. Heath; B Cells Directly Tolerize CD8+ T Cells . J Exp Med 7 December 1998; 188 (11): 1977–1983. doi: https://doi.org/10.1084/jem.188.11.1977
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement